For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Goodfellow gems #129
Wednesday 15 July 2020, 01:00 AM

"Long-term use of the levonorgestrel-releasing intrauterine system and bone mineral density"
Long-term use of the levonorgestrel-releasing intrauterine system (Mirena) does not cause loss of bone mineral density in women and is safe to use.
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
1. https://bit.ly/3emPRsf (BMJ Case Rep 2009;2009:bcr0720080484).
2. https://bit.ly/2NhfJK9 (Hum Reprod 2010;25:1158–64).
3. https://bit.ly/3dmRKns (Nippon Med Sch 2012;79:190–94).
4. https://bit.ly/2BrDZ9S (FSRH CEU Statement 2018).